Justice Seeks Comments on Foreign Agent Registration Form
Published Date: 6/11/2026
Notice
Summary
The Department of Justice wants to update a form (NSD-3) that foreign agents use to register with the government. They’re asking the public to share thoughts by July 13, 2026, to make sure the form works well and isn’t too much work. This update won’t cost extra money but helps keep things clear and fair for everyone involved.
Analyzed Economic Effects
4 provisions identified: 1 benefits, 3 costs, 0 mixed.
Mandatory FARA Exhibit A Registration
If you are a private-sector entity or individual required to register under the Foreign Agents Registration Act (FARA), you must file Exhibit A (Form NSD-3) as part of the registration. The filing is required by statute and regulation, and failure to provide the information is subject to the penalty and enforcement provisions established in Section 8 of FARA.
Filing Fee of $305 Per New Foreign Principal
Every registrant (or person filing on behalf of a registrant) is required to pay a filing fee of $305.00 per new foreign principal under 28 CFR 5.5. The document lists this $305 cost as the total estimated annual other costs burden per new foreign principal.
Estimated Time Burden Is Very Small
The Department estimates 113 respondents will complete Form NSD-3 each year and that each respondent will take 0.22 hours to complete the webform, for a total estimated annual time burden of 24.86 hours. The estimate reflects user testing and the improved e-File webform features.
Electronic e-File Webform Reduces Burden
The Exhibit A (Form NSD-3) is provided as an online e-File webform, and improved e-File features were considered in the burden estimate and may allow electronic submission. These features are intended to enhance clarity and reduce respondent burden.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160, Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-15199, Kerri Zavota, DVM; Decision and Order
2026-15201, Gene M. Koop, D.D.S.; Decision and Order
2026-14836, Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Title-U.S. Official Order Forms for Schedules I and II Controlled Substances DEA Form 222
The DEA is keeping the current rules for ordering the most tightly controlled drugs using DEA Form 222, with no changes. This affects businesses and people who handle Schedule I and II substances, making sure the process stays smooth and secure. They’re asking for public feedback by September 21, 2026, but there’s no new cost or paperwork burden coming your way.
Previous / Next Documents
Previous: 2026-11738, Solicitation of Nominations for Membership on the Presidential Advisory Council on HIV/AIDS
The U.S. Department of Health and Human Services is looking for awesome people to join the Presidential Advisory Council on HIV/AIDS (PACHA). If you care about fighting HIV and want to help shape policies and programs, now’s your chance! Nominations are open for up to four-year terms, but hurry—applications close 30 days after this notice.
Next: 2026-11743, Statement of Organization, Functions, and Delegations of Authority
CMS just launched a new Office of Health Technology and Products to lead the charge in modernizing healthcare tech for Medicare, Medicaid, CHIP, and more. This change started on June 9, 2026, and aims to make digital services faster, smarter, and easier to use—no extra costs announced yet. If you’re involved with these programs, get ready for smoother tech and better digital experiences soon!